What tests do I need right after being diagnosed with Melanoma
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Tests After a Melanoma Diagnosis
After you're diagnosed with melanoma, your care team will order several important tests to understand your cancer better and plan your treatment. Here's what to expect:
Initial Diagnostic Tests
Skin Biopsy (Already Done) You've likely already had a biopsy—a small tissue sample removed from the suspicious area. A pathologist (a doctor who examines tissue under a microscope) will analyze this to confirm melanoma and provide crucial details about your cancer.
Pathology Report Information
Your pathology report will include several key measurements and findings:
Breslow Thickness This measures how deep the melanoma has grown into your skin layers. Thicker melanomas generally require more aggressive treatment and closer follow-up.
Mitotic Rate This counts how many cancer cells are actively dividing in the deeper skin layer (dermis). A higher rate suggests more aggressive cancer.
Ulceration The pathologist checks whether the cancer has broken through the skin surface. This is an important prognostic factor.
Other Features Your report may also note the presence of microsatellites (tiny tumor deposits near the main tumor visible only under a microscope).
Biomarker Testing
According to the NCCN Guidelines for Patients: Melanoma, your doctor may recommend testing for specific genetic mutations:
BRAF Mutation Testing This is particularly important if your melanoma is stage 3 or higher. BRAF mutations are found in about 40-50% of melanomas and can influence treatment decisions. If you have a BRAF V600 mutation, targeted therapy drugs like dabrafenib/trametinib become treatment options.
CDKN2A (p16) Testing This may be recommended, especially if you have a family history of melanoma, as it can indicate hereditary melanoma risk.
Staging Tests
Once your initial diagnosis is confirmed, your care team will order imaging and other tests to determine your cancer's stage (how far it has spread):
Sentinel Lymph Node Biopsy (SLNB) For melanomas thicker than 0.8mm or with other concerning features, this procedure uses dyes and radioactive tracers to identify the first lymph node(s) that drain from your melanoma site. The surgeon removes this "sentinel" node and tests it for cancer cells. This is crucial for staging and treatment planning.
Imaging Studies Depending on your stage, you may need:
- CT (Computed Tomography) scans - detailed X-ray images of your chest, abdomen, and pelvis
- PET scans - imaging that shows areas of high metabolic activity (where cancer might be)
- Brain MRI - if there's concern about spread to the brain
These imaging tests help determine whether cancer has spread beyond the skin and lymph nodes.
Why These Tests Matter
According to the NCCN Guidelines, staging happens twice: first after your initial biopsy, then again after surgery. This two-stage approach is important because surgery often reveals more information about your cancer than the initial biopsy alone.
These test results together tell your doctors:
- How aggressive your cancer is
- Whether it has spread to lymph nodes or distant sites
- Which treatments are most likely to work for your specific cancer
- How often you'll need follow-up care
Questions to Ask Your Care Team
- What is the Breslow thickness of my melanoma?
- Do I need a sentinel lymph node biopsy?
- Should I be tested for BRAF mutations?
- What imaging tests do I need, and when will I get the results?
- Based on these tests, what stage is my melanoma?
- How will these results affect my treatment options?
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Melanoma (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with diagnosis for Melanoma patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: